Multicenter study in Turkiye of unsuppressed viremia in people living with human immunodeficiency virus: aegean experience. [PDF]
Akbulut I+7 more
europepmc +1 more source
Machine Learning-Driven Consensus Modeling for Activity Ranking and Chemical Landscape Analysis of HIV-1 Inhibitors. [PDF]
Danishuddin+5 more
europepmc +1 more source
Higher Genotyping Performance of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit Against ViroSeq HIV-1 Genotyping Kit in HIV <i>Protease</i>, <i>Reverse Transcriptase</i>, and <i>Integrase</i> Regions. [PDF]
Choga OT+7 more
europepmc +1 more source
Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada. [PDF]
Teixeira Nunes Porto LL+6 more
europepmc +1 more source
Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir. [PDF]
D'Antoni ML+5 more
europepmc +1 more source
Diabetes mellitus in patients with HIV naïve to antiretroviral therapy initiating integrase inhibitors therapy. [PDF]
Dias da Costa S+7 more
europepmc +1 more source
First Reported Case of Integrase Strand Transfer Inhibitor Resistance in Suriname: Unusual Drug Resistance Mutations Following Exposure to Dolutegravir. [PDF]
Sno RC, Culbard G, Adhin MR.
europepmc +1 more source
Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study. [PDF]
De Greef J+10 more
europepmc +1 more source
Salvage therapy with an Albuvirtide-based antiretroviral regimen for multi-drug resistant HIV and drug-resistant HBV with renal impairment: a case report. [PDF]
He Y, Liao B, Liu Y, Cao Y, Li L, Cai W.
europepmc +1 more source